Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.

doi:10.1007/s11033-012-1579-y

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.

Molecular biology reports - 1 Jul 2012

Cui Lingling, Dillehay Kelsey, Chen Weimin, Shen Deliang, Dong Zhongyun, Li Wenjie

Abstract excerpt

Cytochrome P450 1B1 (CYP1B1) is a key P450 enzyme involved in the metabolism of exogenous and endogenous substrates in endocrine-mediated tumors such as prostate cancer. The potential significance of nonsynonymous SNP Leu432Val (rs1056836) as a risk factor in prostate cancer has been extensively studied. The objective of this meta-analysis was to quantitatively summarize the association between CYP1B1 Leu432Val...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asian People

Share to Biomarkers, Tumor

Share to Case-Control Studies

Share to Cytochrome P-450 CYP1B1

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk

Source

Open in PubMed

Identifiers

PMID: 22327650
DOI: 10.1007/s11033-012-1579-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.PMID 22327650Read ↗

The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.Semantic proximity Read ↗

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.Semantic proximity Read ↗

Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.Semantic proximity Read ↗

Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.Semantic proximity Read ↗

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.Semantic proximity Read ↗

Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.Semantic proximity Read ↗

Cytochrome P1B1 (CYP1B1) polymorphisms and cancer risk: a meta-analysis of 52 studies.Semantic proximity Read ↗

CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.Semantic proximity Read ↗

Association between the GSTP1 Ile105Val polymorphism and prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.